Qardio, Inc., today received CE Mark and began shipping its revolutionary wearable ECG monitor, QardioCore in the UK and EU. The device is the first wearable medical electrocardiogram (ECG/EKG) monitor allowing users to proactively look after their heart health long-term, all without the need for wires or patches. Packed with proprietary sensor technology, QardioCore records more than 20 million data points a day, streaming the user’s live medical-grade health data to their smartphones. Customers in the United Kingdom, Germany, France, Italy, Spain and all other European Union countries can now purchase the device on www.qardio.com for immediate shipment.
QardioCore is worn as a chest strap and seamlessly records continuous ECG, heart rate, heart rate variability, respiratory rate, temperature and activity data. The data can then be easily and automatically shared, for example, with medical professionals. Athletes can also take advantage of QardioCore to help them achieve peak performance and optimize their training.
QardioCore pairs with the free Qardio App for iOS and works with iPhone, iPad, iPod and integrates with Apple Health. It works alongside Qardio’s other products, including QardioArm, a smart blood pressure monitor, QardioBase, wireless scale and body analyzer and QardioMD, a patient data dashboard for doctors.
QardioCore is priced at EUR499, and GBP449. To order QardioCore, go to: https://www.qardio.com/qardiocore-wearable-ecg-ekg-monitor-iphone/. Qardio plans to roll out QardioCore into other countries it currently sells Qardio products upon receiving regulatory clearance in each market.